Clinical Trials Browser

Phase 1/2 × Recruiting × Neoadjuvant Therapy × Clear all

NCT07385001 2026-02-03

A Prospective, Multicenter, Phase Ib/II Trial of Ivonescimab (AK112) Combined With Albumin-Paclitaxel and Cisplatin as Neoadjuvant Therapy for ESCC

Phase 1/2 Recruiting

Gastrointestinal

Esophageal Squamous Cell Carcinoma